Immediate and late outcomes after direct stent implantation without balloon predilation.

[1]  M. Toussaint,et al.  Direct stent implantation without predilatation using the MultiLink stent. , 1998, The American journal of cardiology.

[2]  Y. Adler,et al.  Coronary Stent Deployment Without Predilation: Prevention of Complications of Venous Graft Angioplasty , 1998, Angiology.

[3]  AlbertSchömig,et al.  Intracoronary Stenting and Risk for Major Adverse Cardiac Events During the First Month , 1998 .

[4]  M. Hadamitzky,et al.  Intracoronary stenting and risk for major adverse cardiac events during the first month. , 1998, Circulation.

[5]  M. Bell,et al.  Frequency of adverse clinical events in the 12 months following successful intracoronary stent placement in patients treated with aspirin and ticlopidine (without warfarin). , 1998, American Journal of Cardiology.

[6]  H. Figulla,et al.  Direct coronary stenting without predilatation: a new therapeutic approach with a special balloon catheter design. , 1998, Catheterization and cardiovascular diagnosis.

[7]  J. Brophy.  Public policy and coronary stenting: a different perspective. , 1998, The Canadian journal of cardiology.

[8]  E. Rechavia,et al.  Long-term follow-up of a high risk cohort after stent implantation in saphenous vein grafts. , 1997, Journal of the American College of Cardiology.

[9]  E. Topol,et al.  Stenting for ischemic heart disease. , 1997, Progress in cardiovascular diseases.

[10]  D. Holmes,et al.  Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. , 1997, The New England journal of medicine.

[11]  M. Leon,et al.  An overview of US coronary stent trials. , 1996, Seminars in interventional cardiology : SIIC.

[12]  W. O’Neill,et al.  Treatment of no-reflow in degenerated saphenous vein graft interventions: comparison of intracoronary verapamil and nitroglycerin. , 1996, Catheterization and cardiovascular diagnosis.

[13]  M. Bell,et al.  Coronary angioplasty and intracoronary thrombolysis are of limited efficacy in resolving early intracoronary stent thrombosis. , 1996, Journal of the American College of Cardiology.

[14]  P. Teirstein,et al.  Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: the multicenter U.S. Palmaz-Schatz stent experience. The Palmaz-Schatz Stent Study Group. , 1995, Journal of the American College of Cardiology.

[15]  J. Marmur,et al.  Adjunctive thrombolytic therapy during angioplasty for ischemic rest angina. Results of the TAUSA Trial. TAUSA Investigators. Thrombolysis and Angioplasty in Unstable Angina trial. , 1994, Circulation.

[16]  Thomas J. Ryan,et al.  Guidelines for Percutaneous Transluminal Coronary Angioplasty A Report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty) , 1993, Circulation.

[17]  E. Topol,et al.  Thrombosis of a flexible coil coronary stent: frequency, predictors and clinical outcome. , 1993, Journal of the American College of Cardiology.

[18]  Guidelines for percutaneous transluminal coronary angioplasty. National PTCA Registry of India. , 1993, Indian heart journal.

[19]  P. Serruys,et al.  Acute Coronary Artery Occlusion During and After Percutaneous Transluminal Coronary Angioplasty: Frequency, Prediction, Clinical Course, Management, and Follow‐up , 1991, Circulation.

[20]  L. Hillis,et al.  Percutaneous transluminal coronary angioplasty. , 1994, The American journal of the medical sciences.

[21]  D. Holmes,et al.  Percutaneous Transluminal Coronary Angioplasty , 1988, The Medical letter on drugs and therapeutics.